Transcriptional activity of metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1) genes differentiates healthy subjects (with coronary artery disease excluded in coronary angiography) from patients with coronary artery disease without heart insufficiency and patients with coronary artery disease complicated by heart failure. This evidence concerns the gene TIMP1 and heart failure.